Answers are grounded in this paper and cite their sources.
In terms of future research around the timing, frequency and composition of follow-ups, this is dependent on the type of cancer being considered. Nevertheless, across most cancers, the possibility of remote follow-up (or testing) by health professionals other than hospital consultants in other settings appears to warrant further work.
No takes yet. Share an insight, caveat, or question.
Barbieri et al. (2018) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: